Tyra Biosciences, Inc. — Director's Dealing 2021

Sep 15, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tyra Biosciences, Inc. (TYRA)
CIK: 0001863127
Period of Report: 2021-09-14

Reporting Person: Verjee Rehan (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.65	2031-06-01	Common Stock (67467)		Direct

Footnotes

F1: 1/36th of the shares subject to the option vest monthly following June 2, 2021, the vesting commencement date.